Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Mar;79(9-10):1468–1474. doi: 10.1038/sj.bjc.6690234

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival

G Ragnarsson 1, G Eiriksdottir 1, J Th Johannsdottir 1, J G Jonasson 1, V Egilsson 1, S Ingvarsson 1
PMCID: PMC2362732  PMID: 10188892

Abstract

The distal half of chromosome 1p was analysed with 15 polymorphic microsatellite markers in 683 human solid tumours at different locations. Loss of heterozygosity (LOH) was observed at least at one site in 369 cases or 54% of the tumours. LOHs detected ranged from 30–64%, depending on tumour location. The major results regarding LOH at different tumour locations were as follows: stomach, 20/38 (53%); colon and rectum, 60/109 (55%); lung, 38/63 (60%); breast, 145/238 (61%); endometrium, 18/25 (72%); ovary, 17/31 (55%); testis, 11/30 (37%); kidney, 22/73 (30%); thyroid, 4/14 (29%); and sarcomas, 9/14 (64%). High percentages of LOH were seen in the 1p36.3, 1p36.1, 1p35–p34.3, 1p32 and 1p31 regions, suggesting the presence of tumour-suppressor genes. All these regions on chromosome 1p show high LOH in more than one tumour type. However, distinct patterns of LOH were detected at different tumour locations. There was a significant separation of survival curves, with and without LOH at chromosome 1p, in the breast cancer patients. Multivariate analysis showed that LOH at 1p in breast tumours is a better indicator for prognosis than the other variables tested in our model, including nodal metastasis. © 1999 Cancer Research Campaign

Keywords: cancer, chromosome 1p, loss of heterozygosity, survival statistics, tumour-suppressor gene

Full Text

The Full Text of this article is available as a PDF (235.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arlt M. F., Herzog T. J., Mutch D. G., Gersell D. J., Liu H., Goodfellow P. J. Frequent deletion of chromosome 1p sequences in an aggressive histologic subtype of endometrial cancer. Hum Mol Genet. 1996 Jul;5(7):1017–1021. doi: 10.1093/hmg/5.7.1017. [DOI] [PubMed] [Google Scholar]
  2. Bardi G., Pandis N., Fenger C., Kronborg O., Bomme L., Heim S. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res. 1993 Apr 15;53(8):1895–1898. [PubMed] [Google Scholar]
  3. Bello M. J., de Campos J. M., Kusak M. E., Vaquero J., Sarasa J. L., Pestaña A., Rey J. A. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer. 1994 Apr;9(4):296–298. doi: 10.1002/gcc.2870090411. [DOI] [PubMed] [Google Scholar]
  4. Bièche I., Champème M. H., Lidereau R. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res. 1994 Aug 15;54(16):4274–4276. [PubMed] [Google Scholar]
  5. Bodmer J. L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schröter M., Becker K. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity. 1997 Jan;6(1):79–88. doi: 10.1016/s1074-7613(00)80244-7. [DOI] [PubMed] [Google Scholar]
  6. Buyse I. M., Takahashi E. I., Huang S. Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics. 1996 May 15;34(1):119–121. doi: 10.1006/geno.1996.0249. [DOI] [PubMed] [Google Scholar]
  7. Caron H., Peter M., van Sluis P., Speleman F., de Kraker J., Laureys G., Michon J., Brugières L., Voûte P. A., Westerveld A. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet. 1995 Apr;4(4):535–539. doi: 10.1093/hmg/4.4.535. [DOI] [PubMed] [Google Scholar]
  8. Caron H., van Sluis P., de Kraker J., Bökkerink J., Egeler M., Laureys G., Slater R., Westerveld A., Voûte P. A., Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 1996 Jan 25;334(4):225–230. doi: 10.1056/NEJM199601253340404. [DOI] [PubMed] [Google Scholar]
  9. Chase P. B., Yang J. M., Thompson F. H., Halonen M., Regan J. W. Regional mapping of the human platelet-activating factor receptor gene (PTAFR) to 1p35-->p34.3 by fluorescence in situ hybridization. Cytogenet Cell Genet. 1996;72(2-3):205–207. doi: 10.1159/000134190. [DOI] [PubMed] [Google Scholar]
  10. Chen L. C., Kurisu W., Ljung B. M., Goldman E. S., Moore D., 2nd, Smith H. S. Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst. 1992 Apr 1;84(7):506–510. doi: 10.1093/jnci/84.7.506. [DOI] [PubMed] [Google Scholar]
  11. Di Vinci A., Infusini E., Peveri C., Risio M., Rossini F. P., Giaretti W. Deletions at chromosome 1p by fluorescence in situ hybridization are an early event in human colorectal tumorigenesis. Gastroenterology. 1996 Jul;111(1):102–107. doi: 10.1053/gast.1996.v111.pm8698188. [DOI] [PubMed] [Google Scholar]
  12. Dracopoli N. C., Harnett P., Bale S. J., Stanger B. Z., Tucker M. A., Housman D. E., Kefford R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4614–4618. doi: 10.1073/pnas.86.12.4614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Duncan A. M., Anderson L. L., Funk C. D., Abramovitz M., Adam M. Chromosomal localization of the human prostanoid receptor gene family. Genomics. 1995 Feb 10;25(3):740–742. doi: 10.1016/0888-7543(95)80022-e. [DOI] [PubMed] [Google Scholar]
  14. Ezaki T., Yanagisawa A., Ohta K., Aiso S., Watanabe M., Hibi T., Kato Y., Nakajima T., Ariyama T., Inazawa J. Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer. 1996 Feb;73(4):424–428. doi: 10.1038/bjc.1996.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haber D., Harlow E. Tumour-suppressor genes: evolving definitions in the genomic age. Nat Genet. 1997 Aug;16(4):320–322. doi: 10.1038/ng0897-320. [DOI] [PubMed] [Google Scholar]
  16. Johnson D. W., Qumsiyeh M., Benkhalifa M., Marchuk D. A. Assignment of human transforming growth factor-beta type I and type III receptor genes (TGFBR1 and TGFBR3) to 9q33-q34 and 1p32-p33, respectively. Genomics. 1995 Jul 20;28(2):356–357. doi: 10.1006/geno.1995.1157. [DOI] [PubMed] [Google Scholar]
  17. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997 Aug 22;90(4):809–819. doi: 10.1016/s0092-8674(00)80540-1. [DOI] [PubMed] [Google Scholar]
  18. Kemper O., Derré J., Cherif D., Engelmann H., Wallach D., Berger R. The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3. Hum Genet. 1991 Sep;87(5):623–624. doi: 10.1007/BF00209026. [DOI] [PubMed] [Google Scholar]
  19. Kuroki T., Fujiwara Y., Tsuchiya E., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer. 1995 Jul;13(3):163–167. doi: 10.1002/gcc.2870130305. [DOI] [PubMed] [Google Scholar]
  20. Kwon B. S., Tan K. B., Ni J., Oh K. O., Lee Z. H., Kim K. K., Kim Y. J., Wang S., Gentz R., Yu G. L. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem. 1997 May 30;272(22):14272–14276. doi: 10.1074/jbc.272.22.14272. [DOI] [PubMed] [Google Scholar]
  21. Lahti J. M., Valentine M., Xiang J., Jones B., Amann J., Grenet J., Richmond G., Look A. T., Kidd V. J. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat Genet. 1994 Jul;7(3):370–375. doi: 10.1038/ng0794-370. [DOI] [PubMed] [Google Scholar]
  22. Lapointe J., Lachance Y., Labrie Y., Labrie C. A p18 mutant defective in CDK6 binding in human breast cancer cells. Cancer Res. 1996 Oct 15;56(20):4586–4589. [PubMed] [Google Scholar]
  23. Lees J. A., Saito M., Vidal M., Valentine M., Look T., Harlow E., Dyson N., Helin K. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol. 1993 Dec;13(12):7813–7825. doi: 10.1128/mcb.13.12.7813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  25. Mathew C. G., Smith B. A., Thorpe K., Wong Z., Royle N. J., Jeffreys A. J., Ponder B. A. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature. 1987 Aug 6;328(6130):524–526. doi: 10.1038/328524a0. [DOI] [PubMed] [Google Scholar]
  26. Mathew S., Murty V. V., Bosl G. J., Chaganti R. S. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res. 1994 Dec 1;54(23):6265–6269. [PubMed] [Google Scholar]
  27. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Modi W. S., Farrar W. L., Howard O. M. Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3-->p31.3 by nonisotopic in situ hybridization. Cytogenet Cell Genet. 1995;69(3-4):232–234. doi: 10.1159/000133971. [DOI] [PubMed] [Google Scholar]
  29. Munn K. E., Walker R. A., Varley J. M. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene. 1995 Apr 20;10(8):1653–1657. [PubMed] [Google Scholar]
  30. Ogunbiyi O. A., Goodfellow P. J., Gagliardi G., Swanson P. E., Birnbaum E. H., Fleshman J. W., Kodner I. J., Moley J. F. Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology. 1997 Sep;113(3):761–766. doi: 10.1016/s0016-5085(97)70169-0. [DOI] [PubMed] [Google Scholar]
  31. Ozawa K., Dean F. B., Chen M., Lee S. H., Shiratori A., Murakami Y., Sakakura T., Hurwitz J., Eki T. Mapping of the 70 kDa, 34 kDa, and 11 kDa subunit genes of the human multimeric single-stranded DNA binding protein (hSSB/RPA) to chromosome bands 17p13, 1p35-p36.1, and 7p21-p22. Cell Struct Funct. 1993 Aug;18(4):221–230. doi: 10.1247/csf.18.221. [DOI] [PubMed] [Google Scholar]
  32. Praml C., Savelyeva L., Le Paslier D., Siracusa L. D., Buchberg A. M., Schwab M., Amler L. C. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199. Cancer Res. 1995 Dec 1;55(23):5504–5506. [PubMed] [Google Scholar]
  33. Rasio D., Murakumo Y., Robbins D., Roth T., Silver A., Negrini M., Schmidt C., Burczak J., Fishel R., Croce C. M. Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res. 1997 Jun 15;57(12):2378–2383. [PubMed] [Google Scholar]
  34. Saito T., Seki N., Matsuda Y., Kitahara M., Murata M., Kanda N., Nomura N., Yamamoto T., Hori T. A. Identification of the human ERK gene as a putative receptor tyrosine kinase and its chromosomal localization to 1p36.1: a comparative mapping of human, mouse, and rat chromosomes. Genomics. 1995 Mar 20;26(2):382–384. doi: 10.1016/0888-7543(95)80224-a. [DOI] [PubMed] [Google Scholar]
  35. Smith S. A., Easton D. F., Evans D. G., Ponder B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet. 1992 Oct;2(2):128–131. doi: 10.1038/ng1092-128. [DOI] [PubMed] [Google Scholar]
  36. Speleman F., Van Camp G., Van Roy N. Reassignment of MYCL1 to human chromosome 1p34.3 by fluorescence in situ hybridization. Cytogenet Cell Genet. 1996;72(2-3):189–190. doi: 10.1159/000134185. [DOI] [PubMed] [Google Scholar]
  37. Steenman M., Redeker B., de Meulemeester M., Wiesmeijer K., Voûte P. A., Westerveld A., Slater R., Mannens M. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet. 1997;77(3-4):296–303. doi: 10.1159/000134602. [DOI] [PubMed] [Google Scholar]
  38. Stock C., Ambros I. M., Lion T., Haas O. A., Zoubek A., Gadner H., Ambros P. F. Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer. 1994 Sep;11(1):40–50. doi: 10.1002/gcc.2870110107. [DOI] [PubMed] [Google Scholar]
  39. Sulman E. P., Tang X. X., Allen C., Biegel J. A., Pleasure D. E., Brodeur G. M., Ikegaki N. ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers. Genomics. 1997 Mar 1;40(2):371–374. doi: 10.1006/geno.1996.4569. [DOI] [PubMed] [Google Scholar]
  40. Taguchi T., Jhanwar S. C., Siegfried J. M., Keller S. M., Testa J. R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res. 1993 Sep 15;53(18):4349–4355. [PubMed] [Google Scholar]
  41. Tanaka K., Yanoshita R., Konishi M., Oshimura M., Maeda Y., Mori T., Miyaki M. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene. 1993 Aug;8(8):2253–2258. [PubMed] [Google Scholar]
  42. Vargas M. P., Zhuang Z., Wang C., Vortmeyer A., Linehan W. M., Merino M. J. Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum Pathol. 1997 Apr;28(4):411–415. doi: 10.1016/s0046-8177(97)90028-9. [DOI] [PubMed] [Google Scholar]
  43. Volpi E. V., Romani M., Siniscalco M. Subregional mapping of the human lymphocyte-specific protein tyrosine kinase gene (LCK) to 1p35-->p34.3 and its position relative to the 1p marker D1S57. Cytogenet Cell Genet. 1994;67(3):187–189. doi: 10.1159/000133819. [DOI] [PubMed] [Google Scholar]
  44. Vorobyov E., Mertsalov I., Dockhorn-Dworniczak B., Dworniczak B., Horst J. The genomic organization and the full coding region of the human PAX7 gene. Genomics. 1997 Oct 1;45(1):168–174. doi: 10.1006/geno.1997.4915. [DOI] [PubMed] [Google Scholar]
  45. White P. S., Maris J. M., Beltinger C., Sulman E., Marshall H. N., Fujimori M., Kaufman B. A., Biegel J. A., Allen C., Hilliard C. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5520–5524. doi: 10.1073/pnas.92.12.5520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wu G. S., Burns T. F., McDonald E. R., 3rd, Jiang W., Meng R., Krantz I. D., Kao G., Gan D. D., Zhou J. Y., Muschel R. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet. 1997 Oct;17(2):141–143. doi: 10.1038/ng1097-141. [DOI] [PubMed] [Google Scholar]
  47. Yamamoto K., Kobayashi H., Miura O., Hirosawa S., Miyasaka N. Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta 1 and beta 2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization. Cytogenet Cell Genet. 1997;77(3-4):257–258. doi: 10.1159/000134589. [DOI] [PubMed] [Google Scholar]
  48. Yeh S. H., Chen P. J., Chen H. L., Lai M. Y., Wang C. C., Chen D. S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994 Aug 1;54(15):4188–4192. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES